Skip to main content
Log in

Inappropriate therapy for MRSA costly, potentially deadly, problem

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Shorr AF, Micek ST, Koffef MH.Inappropriate therapy for methicillin-resistant Staphylococcus aureus: resource utilization and cost implications. Critical Care Medicine 36: 2335-2340, No. 8, Aug 2008

  2. Anderson DJ, Sexton DJ.Inappropriate therapy for staphylococcal infection is common and commonly fatal. Critical Care Medicine 36: 2462-2464, No. 8, Aug 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inappropriate therapy for MRSA costly, potentially deadly, problem. Pharmacoecon. Outcomes News 561, 5 (2008). https://doi.org/10.2165/00151234-200805610-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805610-00006

Keywords

Navigation